Retour
Fourchette du Jour
16,10 €
16,44 €
Fourchette 52 Semaines
13,46 €
31,04 €
Volume
735 783
Moyenne 50J / 200J
22,12 €
/
22,79 €
Clôture Précédente
16,33 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,4 | 0,3 |
| P/B | 0,5 | 2,9 |
| ROE % | -5,4 | 3,7 |
| Net Margin % | -18,8 | 3,8 |
| Rev Growth 5Y % | -24,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
36,00 €
+120.3%
BPA Prévisionnel
-1,41 €
CA Est.
350 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
-1,44 €
-1,46 € – -1,42 €
|
430 M | 1 |
| FY2027 |
-1,48 €
-1,71 € – -1,26 €
|
390 M | 2 |
| FY2026 |
-1,41 €
-1,51 € – -1,30 €
|
350 M | 2 |
Points Clés
Revenue declined -24,49% annually over 5 years
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -124,21M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38,32%
Capital efficient — spends only 7,00% of revenue on capex
Croissance
Revenue Growth (5Y)
-24,49%
Revenue (1Y)13,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-5,39%
ROIC-6,14%
Net Margin-18,75%
Op. Margin-28,23%
Sécurité
Debt / Equity
0,00
Current Ratio6,48
Interest Coverage-1214,61
Valorisation
P/E Ratio
-8,43
P/B Ratio0,46
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,83% | Revenue Growth (3Y) | 5,63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -24,49% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 322,67M | Net Income (TTM) | -60,51M |
| ROE | -5,39% | ROA | -4,99% |
| Gross Margin | 40,56% | Operating Margin | -28,23% |
| Net Margin | -18,75% | Free Cash Flow (TTM) | -124,21M |
| ROIC | -6,14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,48 |
| Interest Coverage | -1214,61 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,43 | P/B Ratio | 0,46 |
| P/S Ratio | 1,58 | PEG Ratio | -0,34 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 510,31M | Enterprise Value | 460,59M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 322,67M | 283,47M | 289,21M | 618,97M | 992,58M |
| Net Income | -60,51M | -42,71M | -167,83M | 143,40M | 507,36M |
| EPS (Diluted) | -1,97 | -1,41 | -5,63 | 4,63 | 16,26 |
| Gross Profit | 130,88M | 107,22M | 104,46M | 366,90M | 777,05M |
| Operating Income | -91,10M | -73,92M | -195,53M | 178,53M | 675,95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,21B | 1,22B | 1,24B | 1,39B | 1,28B |
| Total Liabilities | 106,81M | 90,81M | 102,04M | 116,18M | 112,84M |
| Shareholders' Equity | 1,11B | 1,13B | 1,14B | 1,27B | 1,16B |
| Total Debt | 476 000,0 | 8,47M | 15,25M | 38,94M | 21,28M |
| Cash & Equivalents | 50,19M | 55,14M | 97,47M | 79,51M | 164,89M |
| Current Assets | 550,49M | 353,57M | 507,85M | 627,87M | 611,96M |
| Current Liabilities | 84,97M | 72,90M | 73,02M | 88,11M | 105,31M |